A detailed history of Northern Trust Corp transactions in United Therapeutics Corp stock. As of the latest transaction made, Northern Trust Corp holds 378,556 shares of UTHR stock, worth $138 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
378,556
Previous 362,730 4.36%
Holding current value
$138 Million
Previous $116 Million 17.4%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$311.04 - $363.55 $4.92 Million - $5.75 Million
15,826 Added 4.36%
378,556 $136 Million
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $11.1 Million - $15.5 Million
48,619 Added 15.48%
362,730 $116 Million
Q1 2024

May 14, 2024

SELL
$210.76 - $249.51 $12.6 Million - $14.9 Million
-59,683 Reduced 15.97%
314,111 $72.2 Million
Q4 2023

Feb 13, 2024

SELL
$214.88 - $256.94 $3.8 Million - $4.54 Million
-17,670 Reduced 4.51%
373,794 $82.2 Million
Q3 2023

Nov 13, 2023

SELL
$211.82 - $248.24 $1.07 Million - $1.25 Million
-5,054 Reduced 1.27%
391,464 $88.4 Million
Q2 2023

Aug 11, 2023

BUY
$205.19 - $232.99 $41,858 - $47,529
204 Added 0.05%
396,518 $87.5 Million
Q1 2023

May 15, 2023

BUY
$212.99 - $276.17 $12.4 Million - $16.1 Million
58,133 Added 17.19%
396,314 $88.8 Million
Q4 2022

Feb 13, 2023

BUY
$205.95 - $280.43 $532,174 - $724,631
2,584 Added 0.77%
338,181 $94 Million
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $192,525 - $231,228
-947 Reduced 0.28%
335,597 $70.3 Million
Q2 2022

Aug 12, 2022

SELL
$174.81 - $241.14 $1.01 Million - $1.39 Million
-5,751 Reduced 1.68%
336,544 $79.3 Million
Q1 2022

May 13, 2022

SELL
$166.16 - $213.96 $1.9 Million - $2.45 Million
-11,430 Reduced 3.23%
342,295 $61.4 Million
Q4 2021

Feb 08, 2022

SELL
$184.32 - $216.08 $983,347 - $1.15 Million
-5,335 Reduced 1.49%
353,725 $76.4 Million
Q3 2021

Nov 15, 2021

SELL
$179.86 - $214.88 $1.41 Million - $1.69 Million
-7,845 Reduced 2.14%
359,060 $66.3 Million
Q2 2021

Aug 13, 2021

SELL
$170.47 - $211.93 $1.91 Million - $2.38 Million
-11,211 Reduced 2.96%
366,905 $65.8 Million
Q1 2021

May 12, 2021

BUY
$153.94 - $174.85 $4.27 Million - $4.85 Million
27,724 Added 7.91%
378,116 $63.2 Million
Q4 2020

Feb 11, 2021

SELL
$101.87 - $151.79 $254,267 - $378,867
-2,496 Reduced 0.71%
350,392 $53.2 Million
Q3 2020

Nov 16, 2020

SELL
$99.9 - $121.13 $1.14 Million - $1.38 Million
-11,431 Reduced 3.14%
352,888 $35.6 Million
Q2 2020

Aug 14, 2020

BUY
$92.74 - $125.82 $44,515 - $60,393
480 Added 0.13%
364,319 $44.1 Million
Q1 2020

May 14, 2020

BUY
$79.39 - $115.35 $745,392 - $1.08 Million
9,389 Added 2.65%
363,839 $34.5 Million
Q4 2019

Feb 14, 2020

BUY
$78.31 - $95.34 $850,994 - $1.04 Million
10,867 Added 3.16%
354,450 $31.2 Million
Q3 2019

Nov 13, 2019

SELL
$74.85 - $85.99 $8.42 Million - $9.68 Million
-112,550 Reduced 24.67%
343,583 $27.4 Million
Q2 2019

Aug 13, 2019

SELL
$76.06 - $120.81 $724,395 - $1.15 Million
-9,524 Reduced 2.05%
456,133 $35.6 Million
Q1 2019

May 13, 2019

BUY
$107.15 - $126.84 $3.9 Million - $4.62 Million
36,385 Added 8.48%
465,657 $54.7 Million
Q4 2018

Feb 12, 2019

BUY
$101.4 - $128.73 $1.95 Million - $2.47 Million
19,221 Added 4.69%
429,272 $46.7 Million
Q3 2018

Nov 14, 2018

SELL
$113.81 - $129.46 $3.77 Million - $4.29 Million
-33,112 Reduced 7.47%
410,051 $52.4 Million
Q2 2018

Sep 18, 2018

SELL
$101.14 - $118.31 $274,291 - $320,856
-2,712 Reduced 0.61%
443,163 $50.1 Million
Q2 2018

Aug 14, 2018

BUY
$101.14 - $118.31 $1.45 Million - $1.7 Million
14,367 Added 3.33%
445,875 $50.5 Million
Q1 2018

May 09, 2018

BUY
$107.21 - $151.94 $2.3 Million - $3.26 Million
21,472 Added 5.24%
431,508 $48.5 Million
Q4 2017

Feb 14, 2018

SELL
$118.58 - $151.28 $1.22 Million - $1.56 Million
-10,299 Reduced 2.45%
410,036 $60.7 Million
Q3 2017

Nov 13, 2017

BUY
$114.6 - $136.81 $48.2 Million - $57.5 Million
420,335
420,335 $49.3 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.